Gennova’s mRNA vaccine gets clearance for Phase 2/3 clinical trials

Source: PIB What is the News? India’s first mRNA vaccine against coronavirus named “HGCO19” has been found to be safe and has been given the go-ahead from the Drugs Controller General of India (DCGI) to move into Phase II and III of clinical trials. About HGCO19 Vaccine: The HGCO19 is India’s first mRNA vaccine candidate.… Continue reading Gennova’s mRNA vaccine gets clearance for Phase 2/3 clinical trials